KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Thermo Fisher Scientific (TMO) Gains from Investment Securities (2016 - 2025)

Thermo Fisher Scientific's Gains from Investment Securities history spans 17 years, with the latest figure at $294.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Gains from Investment Securities rose 19.51% year-over-year to $294.0 million, compared with a TTM value of -$21.0 million through Dec 2025, down 162.5%, and an annual FY2025 reading of -$21.0 million, down 162.5% over the prior year.
  • Gains from Investment Securities for Q4 2025 was $294.0 million at Thermo Fisher Scientific, up from -$117.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $294.0 million in Q4 2025, with the low at -$360.0 million in Q4 2022.
  • Average Gains from Investment Securities over 5 years is -$40.1 million, with a median of -$50.0 million recorded in 2023.
  • Year-over-year, Gains from Investment Securities plummeted 5450.0% in 2022 and then skyrocketed 969.57% in 2024.
  • Tracing TMO's Gains from Investment Securities over 5 years: stood at $2.0 million in 2021, then plummeted by 5450.0% to -$107.0 million in 2022, then soared by 121.5% to $23.0 million in 2023, then skyrocketed by 969.57% to $246.0 million in 2024, then increased by 19.51% to $294.0 million in 2025.
  • Per Business Quant, the three most recent readings for TMO's Gains from Investment Securities are $294.0 million (Q4 2025), -$117.0 million (Q3 2025), and -$63.0 million (Q2 2025).